Retatrutide

What is Retatrutide?

Retatrutide (LY3437943) is a synthetic peptide carrying a fatty-acid side chain that promotes albumin binding and extended circulation, supporting once-weekly dosing schedules in clinical research settings. It is distinguished from earlier incretin-based candidates by combining activity at three receptors rather than one or two within a single molecule.

This listing is Retatrutide from Vital Edge Science (Australia & New Zealand), sold on Stairway to Gray with escrow: your payment is held until the order arrives and only then released to the brand.

How it is understood to work

GLP-1 and GIP receptor activation are studied for glucose-dependent insulin secretion, slowed gastric emptying and reduced appetite signaling, mechanisms shared with earlier incretin therapies. The added glucagon-receptor agonism is the distinguishing feature of retatrutide, proposed to increase hepatic fatty-acid oxidation and overall energy expenditure alongside the incretin effects.

Research status

Retatrutide is an investigational compound that has advanced through Phase 2 human clinical trials examining obesity, type 2 diabetes and hepatic fat reduction, with published results describing substantial body-weight and liver-fat changes relative to placebo; it has not received regulatory approval and remains under active clinical investigation, so long-term safety and outcome data are still accumulating.

Specifications

Compound

Retatrutide

Also known as

LY3437943

Class

Investigational triple GLP-1/GIP/glucagon receptor agonist

Form

Lyophilized (freeze-dried) powder

Molecular formula

C221H342N46O68

Molecular weight

~4731.3 g/mol

Brand

Vital Edge Science · Australia & New Zealand

Handling & storage

Supplied as a lyophilized powder; store unopened vials at -20C protected from light, and once reconstituted with bacteriostatic water keep refrigerated at 2-8C for use within the study’s defined timeframe.

Questions

For laboratory research use only. Not for human or veterinary use. Nothing on this page is medical advice.